{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:54:34Z","timestamp":1785610474680,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00702-013-0989-x","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T07:10:49Z","timestamp":1360566649000},"page":"1359-1367","source":"Crossref","is-referenced-by-count":19,"title":["Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats"],"prefix":"10.1007","volume":"120","author":[{"given":"Morgahna Nathalie","family":"Wamser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Fernandes","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Vialle","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Delwing-de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Geraldo Pereira","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela T. S.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"Delwing-Dal Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"989_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","volume":"38","author":"J Bajgar","year":"2004","unstructured":"Bajgar J (2004) Organophosphates\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151\u2013216","journal-title":"Adv Clin Chem"},{"key":"989_CR2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2005.02.012","volume":"1041","author":"CS Bavaresco","year":"2005","unstructured":"Bavaresco CS, Chiarani F, Matte C, Wajner M, Netto CA, Wyse ATS (2005) Effect of hypoxanthine on Na+, K+-ATPase activity and some parameters of oxidative stress in rat striatum. Brain Res 1041:198\u2013204","journal-title":"Brain Res"},{"key":"989_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11011-006-9038-x","volume":"22","author":"CS Bavaresco","year":"2007","unstructured":"Bavaresco CS, Chiarani F, Duringon E, Ferro MM, Cunha CD, Netto CA, Wyse ATS (2007a) Intrastriatal injection of hypoxanthine reduces striatal serotonin content and impairs spatial memory performance in rats. Metab Brain Dis 22:67\u201376","journal-title":"Metab Brain Dis"},{"key":"989_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-006-9037-y","volume":"22","author":"CS Bavaresco","year":"2007","unstructured":"Bavaresco CS, Chiarani F, Wannmacher CM, Netto CA, Wyse ATS (2007b) Intrastriatal hypoxanthine reduces Na(+), K (+)-ATPase activity and induces oxidative stress in the rats. Metab Brain Dis 22:1\u201311","journal-title":"Metab Brain Dis"},{"key":"989_CR5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2008.08.015","volume":"1239","author":"CS Bavaresco","year":"2008","unstructured":"Bavaresco CS, Chiarani F, Kolling J, Ramos DB, Cognato GP, Bonan CD, Bogo MR, Sarkis JJ, Netto CA, Wyse AT (2008) Intrastriatal injection of hypoxanthine alters striatal ectonucleotidase activities: a time-dependent effect. Brain Res 1239:198\u2013206","journal-title":"Brain Res"},{"key":"989_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00093-4","volume":"346","author":"G Benzi","year":"1998","unstructured":"Benzi G, Moretti A (1998) Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer\u2019s disease? Eur J Pharmacol 346:1\u201313","journal-title":"Eur J Pharmacol"},{"key":"989_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"989_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02535748","volume":"25","author":"GW Burton","year":"1990","unstructured":"Burton GW, Wronska U, Stone L, Foster DO, Ingold KU (1990) Biokinetics of dietary RRR-\u03b1-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids 25:199\u2013210","journal-title":"Lipids"},{"key":"989_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","volume":"4","author":"S Darvesh","year":"2003","unstructured":"Darvesh S, Hopkins D, Geula C (2003) Neurobiology of butyrylcholinesterase. Nat Rev Neurobiol 4:131\u2013138","journal-title":"Nat Rev Neurobiol"},{"key":"989_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1021934803724","volume":"18","author":"D Delwing","year":"2003","unstructured":"Delwing D, Chiarani F, Delwing D, Bavaresco CS, Wannmacher CMD, Wajner M, Wyse ATS (2003) Proline reduces acetylcholinesterase activity in cerebral cortex of rats. Metab Brain Dis 18:79\u201386","journal-title":"Metab Brain Dis"},{"key":"989_CR11","first-page":"27","volume":"45","author":"B Dubois","year":"1995","unstructured":"Dubois B, Pillon B (1995) Do cognitive changes of Parkinsons disease result from dopamine depletion? J Neural Transm 45:27\u201334","journal-title":"J Neural Transm"},{"key":"989_CR12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"key":"989_CR13","first-page":"3309","volume":"54","author":"S Fujimori","year":"1996","unstructured":"Fujimori S (1996) PRPP synthetase superactivity. Nihon Rinsho 54:3309\u20133314","journal-title":"Nihon Rinsho"},{"key":"989_CR14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuropsychologia.2004.06.007","volume":"43","author":"M Garcia-Alloza","year":"2005","unstructured":"Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen CP, Francis PT, Lasheras B, Ramirez MJ (2005) Cholinergic\u2013serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer\u2019s disease. Neuropsychologia 43:442\u2013449","journal-title":"Neuropsychologia"},{"key":"989_CR15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1358\/dot.2004.40.8.850473","volume":"40","author":"C Geula","year":"2004","unstructured":"Geula C, Darvesh S (2004) Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer\u2019s disease. Drugs Today 40:711\u2013721","journal-title":"Drugs Today"},{"key":"989_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/exnr.1995.1046","volume":"134","author":"C Geula","year":"1995","unstructured":"Geula C, Mesulam MM, Kuo CC, Tokuno H (1995) Postnatal development of cortical acetylcholinesterase-rich neurons in the rat brain: permanent and transient patterns. Exp Neurol 134:157\u2013178","journal-title":"Exp Neurol"},{"key":"989_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0166-4328(83)90015-3","volume":"9","author":"JJ Hagan","year":"1983","unstructured":"Hagan JJ, Alpert JE, Morris RG, Iversen SD (1983) The effects of central catecholamine depletions on spatial learning in rats. Behav Brain Res 9:83\u2013104","journal-title":"Behav Brain Res"},{"key":"989_CR18","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"1999","unstructured":"Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine. Oxford University Press, London"},{"key":"989_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01800365","volume":"11","author":"RA Harkness","year":"1988","unstructured":"Harkness RA, McCreanor GM, Watts RW (1988) Lesch\u2013Nyhan syndrome and its pathogenesis: purine concentrations in plasma and in urine with metabolite profiles in CSF. J Inher Metab Dis 11:239\u2013252","journal-title":"J Inher Metab Dis"},{"key":"989_CR20","first-page":"1075","volume":"27","author":"JF Henderson","year":"1968","unstructured":"Henderson JF (1968) Possible functions of hypoxanthine\u2013guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch\u2013Nyhan syndrome. Fed Proc 27:1075\u20131077","journal-title":"Fed Proc"},{"key":"989_CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0306-4530(95)00060-7","volume":"21","author":"VW Henderson","year":"1996","unstructured":"Henderson VW, Watt L, Buckwalter JG (1996) Cognitive skills associated with estrogen replacement in women with Alzheimer\u2019s disease. Psychoneuroendocrinology 21:421\u2013430","journal-title":"Psychoneuroendocrinology"},{"key":"989_CR22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3346\/jkms.2004.19.2.209","volume":"19","author":"YS Hong","year":"2004","unstructured":"Hong YS, Lee MJ, Kim KH, Lee SH, Lee YH, Kim BG, Jeong B, Yoon HR, Nishio H, Kim JY (2004) The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men. J Korean Med Sci 19:209\u2013213","journal-title":"J Korean Med Sci"},{"key":"989_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(81)90232-4","volume":"25","author":"ED Jarasch","year":"1981","unstructured":"Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW, Franke WW (1981) Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 25:67\u201382","journal-title":"Cell"},{"key":"989_CR24","first-page":"2537","volume-title":"The metabolic and molecular bases of inherited disease","author":"HA Jinnah","year":"2001","unstructured":"Jinnah HA, Friedmann T (2001) Lesch Nyhan disease and it variants. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2537\u20132569"},{"key":"989_CR25","first-page":"713","volume":"21","author":"AS Klein","year":"1996","unstructured":"Klein AS, Joh JW, Rangan U, Wang D, Bulkley GB (1996) Allopurinol: discrimination of antioxidant from enzyme inhibitory activities. Free radical. Biol Med 21:713\u2013717","journal-title":"Biol Med"},{"key":"989_CR26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9343(64)90104-4","volume":"36","author":"M Lesch","year":"1964","unstructured":"Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36:561\u2013570","journal-title":"Am J Med"},{"key":"989_CR27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM198111053051902","volume":"305","author":"KG Lloyd","year":"1981","unstructured":"Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox IH (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch\u2013Nyhan syndrome. N Engl J Med 305:1106\u20131111","journal-title":"N Engl J Med"},{"key":"989_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01738910","volume":"189","author":"O Loewi","year":"1921","unstructured":"Loewi O (1921) Uberhumerole ubertragbarkeit der herznervenwirkung. I Mitteilung Pflugers Arch 189:239\u2013242","journal-title":"I Mitteilung Pflugers Arch"},{"key":"989_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0301-0082(93)90040-Y","volume":"41","author":"J Massoulie","year":"1993","unstructured":"Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM (1993) Molecular and cellular biology of cholinesterases. Prog Neurobiol 41:31\u201391","journal-title":"Prog Neurobiol"},{"key":"989_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-0102(02)00201-8","volume":"45","author":"JB Melo","year":"2003","unstructured":"Melo JB, Agostinho P, Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45:117\u2013127","journal-title":"Neurosci Res"},{"key":"989_CR31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","volume":"170","author":"MM Mesulam","year":"2002","unstructured":"Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyse acetylcholine. Neuroscience 170:627\u2013639","journal-title":"Neuroscience"},{"key":"989_CR32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/mds.10472","volume":"18","author":"A Mura","year":"2003","unstructured":"Mura A, Feldon J (2003) Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system. Mov Disord 18:860\u2013871","journal-title":"Mov Disord"},{"key":"989_CR33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0165-0173(02)00268-0","volume":"41","author":"T Myhrer","year":"2000","unstructured":"Myhrer T (2000) Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Rev 41:268\u2013287","journal-title":"Brain Res Rev"},{"key":"989_CR34","first-page":"22","volume":"147","author":"WL Nyhan","year":"2005","unstructured":"Nyhan WL (2005) Inherited hyperuricemic disorders. Contrib Nephrol 147:22\u201334","journal-title":"Contrib Nephrol"},{"key":"989_CR35","first-page":"439","volume":"67","author":"WL Nyhan","year":"1965","unstructured":"Nyhan WL, Oliver WJ, Lesch M (1965) A familial disorder or uric acid metabolism and central nervous system function II. J Pediatr 67:439\u2013444","journal-title":"J Pediatr"},{"key":"989_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008571-200304000-00008","volume":"13","author":"KK O\u2032Brien","year":"2003","unstructured":"O\u2032Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O\u2032Brien JT, Swan AG, Fairbairn AF, Wesnes K, del Ser T, Edwardson JA, Morris CM, McKeith IG (2003) Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 13:231\u2013239","journal-title":"Pharmacogenetics"},{"key":"989_CR37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303\u2013308","journal-title":"Arch Neurol"},{"key":"989_CR38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/978-3-642-84962-6_3","volume-title":"Molecular genetics, biochemistry and clinical aspects of inherited disorders of purine and pyrimidine metabolism","author":"JG Puig","year":"1993","unstructured":"Puig JG, Mateos FA (1993) The biochemical basis of HGPRT deficiency. In: Gresser U (ed) Molecular genetics, biochemistry and clinical aspects of inherited disorders of purine and pyrimidine metabolism. Springer, New York, pp 12\u201326"},{"key":"989_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00271165","volume":"57","author":"G Rijksen","year":"1981","unstructured":"Rijksen G, Staal GEJ, Van der Vlist MJM, Beerner FA, Troost J, Gutensohn W, Van Laarhoven JPRM, De Bruyn CHMM (1981) Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch\u2013Nyhan syndrome. Hum Genet 57:39\u201347","journal-title":"Hum Genet"},{"key":"989_CR40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.1967.03130160049007","volume":"202","author":"RM Rosenbloom","year":"1967","unstructured":"Rosenbloom RM, Henderson JF, Caldwell IC, Kelley WN, Seegmiller JE (1967) Inherited disorder of purine metabolism. JAMA 202:175\u2013177","journal-title":"JAMA"},{"key":"989_CR41","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S0387-7604(00)00143-1","volume":"22","author":"Y Saito","year":"2000","unstructured":"Saito Y, Takashima S (2000) Neurotransmitter changes in the pathophysiology of Lesch\u2013Nyhan syndrome. Brain Dev 22:S122\u2013S131","journal-title":"Brain Dev"},{"key":"989_CR42","first-page":"45","volume":"44","author":"CG Silva","year":"2004","unstructured":"Silva CG, Bueno ARF, Schuck PF, Leipnitz G, Ribeiro CA, Rosa RB, Dutra Filho CS, Wyse AT, Wannmacher CM, Wajner M (2004) Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neuchem Int 44:45\u201352","journal-title":"Neuchem Int"},{"key":"989_CR43","volume-title":"The biology of cholinesterases","author":"A Silver","year":"1974","unstructured":"Silver A (1974) The biology of cholinesterases. North-Holland, Amsterdam"},{"key":"989_CR44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajmg.10217","volume":"108","author":"T Srivastava","year":"2002","unstructured":"Srivastava T, O\u2019Neill JP, Dasouki M, Simckes AM (2002) Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. Am J Med Gene 108:219\u2013222","journal-title":"Am J Med Gene"},{"key":"989_CR45","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s11064-007-9464-0","volume":"32","author":"FM Stefanello","year":"2007","unstructured":"Stefanello FM, Monteiro SC, Matt\u00e9 C, Scherer EBS, Netto CS, Wyse ATS (2007) Hypermethioninemia increases cerebral acetylcholinesterase activity and impairs memory in rats. Neurochem Res 32:1868\u20131874","journal-title":"Neurochem Res"},{"key":"989_CR46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","volume":"8","author":"RJ Torres","year":"2007","unstructured":"Torres RJ, Puig JG (2007) Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: Lesch\u2013Nyhan syndrome. Orphanet J Rare Dis 8:48","journal-title":"Orphanet J Rare Dis"},{"key":"989_CR47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-9120(99)00090-9","volume":"33","author":"S Tsakiris","year":"2000","unstructured":"Tsakiris S, Angelogianni P, Schulpis KH, Stavridis JC (2000) Protective effect of l-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin Biochem 33:103\u2013106","journal-title":"Clin Biochem"},{"key":"989_CR48","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjp.2008.185","volume":"154","author":"I Wessler","year":"2008","unstructured":"Wessler I, Kirkpatrick CJ (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154:1558\u20131571","journal-title":"Br J Pharmacol"},{"key":"989_CR49","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1023\/A:1021647329937","volume":"27","author":"ATS Wyse","year":"2002","unstructured":"Wyse ATS, Zugno AI, Streck EL, Matte C, Calcagnotto T, Wannmacher CMD, Wajner M (2002) Inhibition of Na+, K+-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685\u20131689","journal-title":"Neurochem Res"},{"key":"989_CR50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:NERE.0000013741.81436.e8","volume":"29","author":"ATS Wyse","year":"2004","unstructured":"Wyse ATS, Stefanello FM, Chiarani F, Delwing D, Wannmacher CMD, Wajner M (2004) Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction. Neurochem Res 29:385\u2013389","journal-title":"Neurochem Res"},{"key":"989_CR51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cccn.2005.01.024","volume":"356","author":"T Yamamoto","year":"2005","unstructured":"Yamamoto T, Moriwaki Y, Takahashi S (2005) Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin Chim Acta 356:35\u201357","journal-title":"Clin Chim Acta"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-0989-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-0989-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-0989-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:30:23Z","timestamp":1559104223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-0989-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-0989-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]}}}